Trial · NCT06999135
Comparison of Silodosin and Tamsulosin for Medical Expulsive Therapy in Patients With Ureteral Stones
NCT06999135, Not applicable, Completed, Fatima Jinnah Medical University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of Silodosin and Tamsulosin for Medical Expulsive Therapy in Patients With Ureteral Stones. Trials, record NCT06999135. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06999135
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of Silodosin and Tamsulosin for Medical Expulsive Therapy in Patients With Ureteral Stones
- NCT number
- NCT06999135
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 200 participants, actual
- Lead sponsor
- Fatima Jinnah Medical University
- Conditions
- Tamsulosin, Silodosin, Medical Expulsive Therapy
- Interventions
- Silodosin
- First posted
- 2025-05-31
- Last updated
- 2025-05-31
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | STONE EXPULSION RATE | 6 MONTHS | This measure evaluates the proportion of patients who pass ureteral stones within specific time frames (0-14 days, 15-21 days, and 22-28 days) when treated with Silodosin versus Tamsulosin. |
| Primary | TIME TO STONE EXPULSION | 6MONTHS | Number of days from treatment initiation to confirmed stone passage, measured by imaging and patient report. |
| Secondary | INCIDENCE OF ORTHOSTATIC HYPOTENSION | 6 months | Percentage of patients experiencing orthostatic hypotension, measured by clinical blood pressure monitoring. |
| Secondary | Incidence of Abnormal Ejaculation | 6 months | Percentage of patients reporting abnormal ejaculation, assessed via patient questionnaires. |
| Secondary | Incidence of Headache Percentage of patients reporting headaches, assessed via patient questionnaires. | 6 months | Percentage of patients reporting headaches, assessed via patient questionnaires. |
| Secondary | Analgesic Requirement: | 6 months | Percentage of patients requiring analgesics during treatment, recorded from prescription or patient report. |
| Secondary | Need for Auxiliary Procedures | 6 months | Percentage of patients requiring interventions such as ureteroscopy or lithotripsy, documented from clinical records. |
| Secondary | Stone Position and Laterality | 6 months | : Distribution of stone location (proximal, mid, distal ureter) and side (right or left), determined by imaging. |
| Secondary | Symptom Duration Prior to CT: | 6 months | Categorized duration of symptoms before diagnosis, collected from patient history. |
| Other | BMI | 6 MONTHS | Measurement: Categorized as Normal or Obese based on standard BMI thresholds (weight in kilograms divided by height in meters squared). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers16
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06999135
GET https://conductscience.org/api/trials/v1/NCT06999135/registered